Abstract

Eegala Bheema Shankar¹, Challa Gangu Naidu^1,2, Subramani Devaraju^1*, K Varaprasada Rao4, Bondigalla Ramachandra³, Y. Srinivasa Rao⁴ and Satwinder S Marok⁵

DOI : http://dx.doi.org/10.13005/ojc/400124

Besifloxacin is a fourth-generation fluoroquinolone and shows significant antibacterial properties, which works well against a range of bacteria. Besifloxacin ophthalmic solution is the name of the specific form of this medication used to treat eye infections. The vortex-assisted chiral ionic liquid method was used for the separation of Besifloxacin isomers. S- Besifloxacin shows antibacterial action in clinical trials. The R-isomer, however, has not shown biological properties in clinical testing through different cell line. The current proposed chiral assay method was developed between a racemic mixture and a chiral selector. The analytical databases affirm that 1, 2 dichloroethane is used as a non-aqueous (organic media) solvent and that 1,3-butyl-3-methylimidazole L-tryptophan ([Bmim] [Ltrp]) opted used as a specific chiral ionic liquid. The developed ionic liquid based chital hplc method was successfully applied to separation and purification of isomers of Besifloxacin in during the process industries in bulk drugs.

Besifloxacin; Chiral Ionic Liquid; Two-phase Separation; Zero-point energy

[ View HTML Full Text]